Achieve Life Sciences (ACHV) Tops Q3 EPS by 40c; Reports Cash and Cash Equivalents of $33.4M
Tweet
Share
E-mailGet Alerts ACHV Hot Sheet
Join SI Premium – FREE
Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.71), $0.40 better than the analyst estimate of ($1.11).
For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- FDA rejects Achieve Life Sciences drug application over manufacturing issues
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
